PRADAXA OR WARFARIN FOR PREVENTION OF RECURRENT VTE IN PATIENTS WITH ANGIOGRAPHICALLY CONFIRMED ACUTE MASSIVE PULMONARY EMBOLISM UNDERGOING ENDOVASCULAR MECHANICAL FRAGMENTATION AND THROMBOLYTIC THERAPY: